CNTN1 was discovered as a potential RET-PTC3 downstream gene in GEO profile database and RET inhibitor regorafenib successfully downregulated CNTN1 expression in thyroid cancer cells [7]. This evidence concerns the gene NCOA4 and thyroid gland carcinoma.